Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Publishing Office, 2017.
Subjects:	Pharmaceutical industry > Corrupt practices > United States. Pharmaceutical policy > United States. Generic drugs > Development > United States. Prescription pricing > United States. Competition > United States. Consumer protection > United States. Legislative hearings.
Online Access:	https://purl.fdlp.gov/GPO/gpo86757 http://purl.fdlp.gov/GPO/gpo86757

Available Online